BUSINESS● LOWJun 23 · Jun 23, 2026, 10:28 AM
Organon and Henlius launch Prolia and Xgeva biosimilars in Canada
Seeking Alpha Tech
Organon and Henlius have launched biosimilars for Prolia and Xgeva in Canada. This marks a new development in the Canadian pharmaceutical market.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS19m agoAustralia’s Sydney Airport staff shortages prompt plan to close tower overnightSouth China Morning PostBUSINESS40m agoOil prices fall as Saudi supply hopes outweigh fresh Houthi strikesCNBC